Literature DB >> 25808708

Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations.

Stacy Loeb1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25808708     DOI： 10.1111/bju.12966

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  4 in total

1.  Systematic Differences Between Total and Free Prostate-Specific Antigen Immunoassays: Comparison Using Passing and Bablok Regression.

Authors:  Nafija Serdarevic; Pradeep Dabla; Adina Elena Stanciu
Journal:  Indian J Clin Biochem       Date:  2019-02-13

2.  Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.

Authors:  Montserrat Ferrer-Batallé; Esther Llop; Manel Ramírez; Rosa Núria Aleixandre; Marc Saez; Josep Comet; Rafael de Llorens; Rosa Peracaula
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

3.  Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL.

Authors:  Joongwon Choi; Minyong Kang; Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee
Journal:  Investig Clin Urol       Date:  2020-11

4.  Influence of age on seven putative prostate tumor markers: a cohort study in Chinese men.

Authors:  Wei-Gui Sun; Chao-Zhao Liang; Qi-Chuan Zheng; Xiao-Wu Hu; Zhi-Zhen Li; Ping Wu
Journal:  Asian J Androl       Date:  2017 Jul-Aug       Impact factor: 3.285
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.